All Stories

  1. Analytical performance of the VITA™ point-of-care CD4 enumeration assay
  2. An extension of the Spiegelhalter-Knill-Jones method for continuous covariates in clinical decision making
  3. Guidelines for Integrating actionable A-SMART Learning Outcomes into the Backward Design Process
  4. COVID-19 outbreaks in endangered Indigenous groups from the Amazonia during the first wave of the COVID-19 pandemic in Ecuador: a retrospective cross-sectional study
  5. Ethnic, geographical and altitude considerations and maternal mortality associated with HELLP syndrome in Ecuador: a population-based cohort study
  6. clinical prediction score
  7. Development of antepartum risk prediction model for postpartum hemorrhage in Lagos, Nigeria: A prospective cohort study (Predict‐PPH study)
  8. Shaping the future of global access to safe, effective, appropriate and quality health products
  9. Piloting a new method to estimate action thresholds in medicine through intuitive weighing
  10. Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry
  11. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
  12. High SARS-CoV-2 infection rates and viral loads in community-dwelling individuals from rural indigenous and mestizo communities from the Andes during the first wave of the COVID-19 pandemic in Ecuador
  13. Ethnodemographic characterization of stroke incidence and burden of disease in hospital discharge records in Ecuador
  14. The therapeutic threshold in clinical decision-making for TB
  15. Sustained COVID-19 community transmission and potential super spreading events at neglected afro-ecuadorian communities assessed by massive RT-qPCR and serological testing of community dwelling population
  16. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
  17. Carga de enfermedad por cáncer de cuello uterino en Ecuador, periodo 2015-2020
  18. SARS-CoV-2 Viral Load Analysis at Low and High Altitude: A Case Study from Ecuador
  19. Female homicides and femicides in Ecuador: a nationwide ecological analysis from 2001 to 2017
  20. HIV Rapid Testing in the General Population and the Usefulness of PrEP in Ecuador: A Cost–Utility Analysis
  21. High SARS-CoV-2 Infection Rates Among Special Forces Police Units During the Early Phase of the COVID-19 Pandemic in Ecuador
  22. Diagnostic Performance of Seven Commercial COVID-19 Serology Tests Available in South America
  23. Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multic...
  24. Crucial contribution of the universities to SARS-CoV-2 surveillance in Ecuador: Lessons for developing countries
  25. Carga de enfermedad por insuficiencia cardiaca en Ecuador durante el periodo 2014-2018
  26. Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort
  27. Stroke-Related Mortality at Different Altitudes: A 17-Year Nationwide Population-Based Analysis From Ecuador
  28. COVID-19 outbreaks among isolated Amazonian indigenous people, Ecuador
  29. COVID-19 outbreaks at shelters for women who are victims of gender-based violence from Ecuador
  30. COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
  31. High prevalence of SARS-CoV-2 infection among food delivery riders. A case study from Quito, Ecuador
  32. Massive SARS-CoV-2 RT-PCR Testing on Rural Communities in Manabi Province (Ecuador) Reveals Severe COVID-19 Outbreaks
  33. Testing for SARS-CoV-2 at the core of voluntary collective isolation: Lessons from the indigenous populations living in the Amazon region in Ecuador
  34. A population-based study of preeclampsia and eclampsia in Ecuador: ethnic, geographical and altitudes differences
  35. Epidemiological, socio-demographic and clinical features of the early phase of the COVID-19 epidemic in Ecuador
  36. Assessing the burden and spatial distribution of Taenia solium human neurocysticercosis in Ecuador (2013–2017)
  37. The burden of cutaneous and mucocutaneous leishmaniasis in Ecuador (2014-2018), a national registry-based study
  38. Thyroid Cancer in Ecuador, a 16 years population-based analysis (2001–2016)
  39. The burden of acute respiratory infections in Ecuador 2011-2015
  40. Rational use of Xpert testing in patients with presumptive TB: clinicians should be encouraged to use the test-treat threshold
  41. The disease burden of suicide in Ecuador, a 15 years’ geodemographic cross-sectional study (2001–2015)
  42. Costo De La Inmunización De Rutina En Menores De Un Año En El Año 2016 En El Ecuador
  43. Costo-Efectividad De La Deteccion De Adn De Virus De Papiloma Humano De Alto Riesgo Para Tamizaje De Cancer De Cuello Uterino En Ecuador
  44. Analysis of the cost–effectiveness of carbetocin for the prevention of hemorrhage following cesarean delivery in Ecuador
  45. Cost Of Dengue Illness And Cost-Effectiveness Of The Cdy-Tdv Dengue Vaccine In Ecuador
  46. Analysis of Health and Drug Access Associated with the Purchasing Power of the Ecuadorian Population
  47. Bias control in shared decision making: still too many loose ends
  48. Can we improve adherence to guidelines for the treatment of lower urinary tract infection? A simple, multifaceted intervention in out-of-hours services
  49. Comment on ‘A qualitative approach to Bayes’ theorem' by Medow and Lucey